Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Bang YJ, Kang YK, Kang WK, Boku N, Chung HC, Chen JS, Doi T, Sun Y, Shen L, Qin S, Ng WT, Tursi JM, Lechuga MJ, Lu DR, Ruiz-Garcia A, Sobrero A.
Bang YJ, et al. Among authors: doi t.
Invest New Drugs. 2011 Dec;29(6):1449-58. doi: 10.1007/s10637-010-9438-y. Epub 2010 May 12.
Invest New Drugs. 2011.
PMID: 20461441
Free PMC article.
Clinical Trial.